scholarly journals Relative preservation of triceps over biceps strength in upper limb-onset ALS: the ‘split elbow’

2019 ◽  
Vol 90 (7) ◽  
pp. 730-733 ◽  
Author(s):  
Roaya Khalaf ◽  
Sarah Martin ◽  
Cathy Ellis ◽  
Rachel Burman ◽  
Jemeen Sreedharan ◽  
...  

ObjectiveAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of the motor system. The split hand sign in ALS refers to observed preferential weakness of the lateral hand muscles, which is unexplained. One possibility is larger cortical representation of the lateral hand compared with the medial. Biceps strength is usually preserved relative to triceps in neurological conditions, but biceps has a larger cortical representation and might be expected to show preferential weakness in ALS.MethodsUsing the South-East England Register for Amyotrophic Lateral Sclerosis, we performed a retrospective longitudinal cohort study and extracted the modified Medical Research Council (MRC) muscle strength score for biceps and triceps in patients with a diagnosis of upper limb-onset ALS in the 19-year period 1996–2015. A Wilcoxon signed-rank test was used to assess the relative strength of the muscles within the total sum of the upper limbs involved in the study.ResultsThere were 659 people with upper limb onset of weakness. In 215 there were insufficient data to perform the analysis, and a further 33 were excluded for other reasons, leaving 411 for analysis. Biceps was stronger than triceps in 87 limbs, and triceps was stronger than biceps in 258 limbs, with no difference seen in the remaining 477. Triceps strength scores (mean rank=186.1) were higher than ipsilateral biceps strength scores (mean rank=134.2), Z=−10.1, p<0.001 (two-tailed).ConclusionTriceps strength is relatively preserved compared with biceps in ALS. This is consistent with a broadly corticofugal hypothesis of selective vulnerability, in which susceptibility might be associated with larger cortical representation.

2009 ◽  
Vol 92 (3) ◽  
pp. 261-264 ◽  
Author(s):  
J. Martí-Fàbregas ◽  
M. Dourado ◽  
J. Sanchis ◽  
R. Miralda ◽  
J. Pradas ◽  
...  

2014 ◽  
Vol 23 (3) ◽  
pp. 253-257 ◽  
Author(s):  
Byung-Nam Yoon ◽  
Seong Hye Choi ◽  
Joung-Ho Rha ◽  
Sa-Yoon Kang ◽  
Kwang-Woo Lee ◽  
...  

2021 ◽  
Vol 14 (8) ◽  
pp. 705
Author(s):  
Hideki Houzen ◽  
Takahiro Kano ◽  
Kazuhiro Horiuchi ◽  
Masahiro Wakita ◽  
Azusa Nagai ◽  
...  

Reports on the long-term survival effect of edaravone, which was approved for the treatment of amyotrophic lateral sclerosis (ALS) in 2015 in Japan, are rare. Herein, we report our retrospective analysis of 45 consecutive patients with ALS who initially visited our hospital between 2013 and 2018. Of these, 22 patients were treated with edaravone for an average duration of 26.6 (range, 2–64) months, whereas the remaining patients were not treated with edaravone and comprised the control group. There were no differences in baseline demographics between the two groups. The primary endpoint was tracheostomy positive-pressure ventilation (TPPV) or death, and the follow-up period ended in December 2020. The survival rate was significantly better in the edaravone group than in the control group based on the Kaplan–Meier analysis, which revealed that the median survival durations were 49 (9–88) and 25 (8–41) months in the edaravone and control groups, respectively (p = 0.001, log-rank test). There were no serious edaravone-associated adverse effects during the study period. Overall, the findings of this single-center retrospective study suggest that edaravone might prolong survival in patients with ALS.


2007 ◽  
Vol 29 (1-2) ◽  
pp. 44-48 ◽  
Author(s):  
K. Abhinav ◽  
B. Stanton ◽  
C. Johnston ◽  
J. Hardstaff ◽  
R.W. Orrell ◽  
...  

Author(s):  
Robert Laureno

This chapter on “Selective Vulnerability” examines the selective vulnerability of different parts of the brain to particular diseases. In one disease, certain areas of brain are particularly vulnerable. In other diseases, different parts of the brain are more susceptible. The concept of selective vulnerability was originally applied to toxic/metabolic and hereditary disorders, but it is also useful in thinking about other neuropathologic processes including neoplastic, infectious, demyelinative, vascular, and traumatic diseases. Diseases can selectively affect brain systems, brain structures, or brain regions. Selective system involvement is clear in degenerative diseases such as amyotrophic lateral sclerosis; selective structure involvement occurs in carbon monoxide’s effect on the globus pallidus; selective region involvement is found in myelinolysis.


2019 ◽  
Vol 84 ◽  
pp. 178-188 ◽  
Author(s):  
Foteini Christidi ◽  
Efstratios Karavasilis ◽  
Michail Rentzos ◽  
Georgios Velonakis ◽  
Vasiliki Zouvelou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document